Tozorakimab for COPD, BTK Inhibitor Timing, and Creatine's Cancer Risk

In today's episode we cover six new studies: a monoclonal antibody that cuts COPD exacerbations, a real-world study on BTK inhibitor dosing in chronic lymphocytic leukemia, SGLT2 inhibitors in Fabry disease, a surprising creatine and cancer metastasis link, new Alzheimer's genetics beyond APOE, and how caloric restriction affects DNA mutations in mice. We also round up several other notable papers in genomics and oncology.